UBS lowered its price target for UiPath from $19 to $15, citing uncertainty about long-term revenue growth after the company's Investor Day. Meanwhile, Needham remains optimistic with a $22 price target, highlighting UiPath's AI automation products like Cartographer and Test Cloud as growth drivers. Despite these differing views, UiPath's stock has fallen about 24% since late August, reflecting market concerns over growth visibility. The company's AI-focused product innovations keep some analysts bullish on its future potential.
UiPath's stock is trading at USD 12.46 on Pluang, down 1.11% in the past day with a market cap of $6.49 billion. Most Pluang users are selling, with 97% of order activity on the platform being sell orders as of Sep 27, 2026 04:31 WIB.
